Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo‐Controlled, Phase II Trial

Omiganan is an indolicidin analog with antimicrobial properties that could be beneficial for patients with atopic dermatitis. In this randomized, double‐blind, placebo‐controlled, phase II trial we explored the efficacy, pharmacodynamics, and safety of topical omiganan once daily in 36 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Niemeyer‐van der Kolk, Tessa, van der Wall, Hein, Hogendoorn, Geretta K., Rijneveld, Rianne, Luijten, Sascha, van Alewijk, Dirk C.J.G., van den Munckhof, Ellen H.A., de Kam, Marieke L., Feiss, Gary L., Prens, Errol P., Burggraaf, Jacobus, Rissmann, Robert, van Doorn, Martijn B.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485951/
https://www.ncbi.nlm.nih.gov/pubmed/32315497
http://dx.doi.org/10.1111/cts.12792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485951/
https://www.ncbi.nlm.nih.gov/pubmed/32315497
http://dx.doi.org/10.1111/cts.12792

Ejemplares similares